Danaher Total Current Assets 2010-2025 | DHR
Danaher total current assets from 2010 to 2025. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
- Danaher total current assets for the quarter ending March 31, 2025 were $9.525B, a 33.73% decline year-over-year.
- Danaher total current assets for 2024 were $9.497B, a 31.86% decline from 2023.
- Danaher total current assets for 2023 were $13.937B, a 12.25% decline from 2022.
- Danaher total current assets for 2022 were $15.883B, a 36.36% increase from 2021.
| Danaher Annual Total Current Assets (Millions of US $) |
|
|---|---|
| 2024 | $9,497 |
| 2023 | $13,937 |
| 2022 | $15,883 |
| 2021 | $11,648 |
| 2020 | $13,802 |
| 2019 | $25,596 |
| 2018 | $7,094 |
| 2017 | $6,850 |
| 2016 | $6,665 |
| 2015 | $7,837 |
| 2014 | $9,431 |
| 2013 | $9,114 |
| 2012 | $7,588 |
| 2011 | $6,272 |
| 2010 | $6,065 |
| 2009 | $5,221 |
| Danaher Quarterly Total Current Assets (Millions of US $) |
|
|---|---|
| 2025-03-31 | $9,525 |
| 2024-12-31 | $9,497 |
| 2024-09-30 | $10,060 |
| 2024-06-30 | $9,609 |
| 2024-03-31 | $14,372 |
| 2023-12-31 | $13,937 |
| 2023-09-30 | $21,205 |
| 2023-06-30 | $17,461 |
| 2023-03-31 | $16,532 |
| 2022-12-31 | $15,883 |
| 2022-09-30 | $14,250 |
| 2022-06-30 | $13,229 |
| 2022-03-31 | $12,670 |
| 2021-12-31 | $11,648 |
| 2021-09-30 | $10,776 |
| 2021-06-30 | $15,392 |
| 2021-03-31 | $14,012 |
| 2020-12-31 | $13,802 |
| 2020-09-30 | $12,541 |
| 2020-06-30 | $12,344 |
| 2020-03-31 | $11,143 |
| 2019-12-31 | $25,596 |
| 2019-09-30 | $20,354 |
| 2019-06-30 | $11,604 |
| 2019-03-31 | $10,080 |
| 2018-12-31 | $7,094 |
| 2018-09-30 | $6,831 |
| 2018-06-30 | $6,913 |
| 2018-03-31 | $7,075 |
| 2017-12-31 | $6,850 |
| 2017-09-30 | $6,260 |
| 2017-06-30 | $6,257 |
| 2017-03-31 | $6,319 |
| 2016-12-31 | $6,665 |
| 2016-09-30 | $6,493 |
| 2016-06-30 | $11,231 |
| 2016-03-31 | $7,747 |
| 2015-12-31 | $7,837 |
| 2015-09-30 | $8,932 |
| 2015-06-30 | $9,655 |
| 2015-03-31 | $8,774 |
| 2014-12-31 | $9,431 |
| 2014-09-30 | $9,990 |
| 2014-06-30 | $9,507 |
| 2014-03-31 | $9,404 |
| 2013-12-31 | $9,114 |
| 2013-09-30 | $8,024 |
| 2013-06-30 | $8,231 |
| 2013-03-31 | $7,910 |
| 2012-12-31 | $7,588 |
| 2012-09-30 | $6,908 |
| 2012-06-30 | $6,610 |
| 2012-03-31 | $6,543 |
| 2011-12-31 | $6,272 |
| 2011-09-30 | $6,315 |
| 2011-06-30 | $6,555 |
| 2011-03-31 | $6,132 |
| 2010-12-31 | $6,065 |
| 2010-09-30 | $5,461 |
| 2010-06-30 | $5,045 |
| 2010-03-31 | $4,541 |
| 2009-12-31 | $5,221 |
| 2009-09-30 | $5,199 |
| 2009-06-30 | $4,789 |
| 2009-03-31 | $4,497 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $142.275B | $23.875B |
| Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVS Health (CVS) | United States | $86.641B | 10.77 |
| Elevance Health (ELV) | United States | $86.192B | 11.12 |
| Cencora (COR) | United States | $58.034B | 20.19 |
| DiDi Global (DIDIY) | China | $23.015B | 24.45 |
| Natera (NTRA) | United States | $22.934B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.811B | 17.69 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.798B | 0.00 |
| Solventum (SOLV) | United States | $13.056B | 13.82 |
| CochLear (CHEOY) | Australia | $12.649B | 0.00 |
| ICON (ICLR) | Ireland | $11.674B | 10.85 |
| Revvity (RVTY) | United States | $11.530B | 19.84 |
| Viatris (VTRS) | United States | $10.575B | 3.63 |
| Avantor (AVTR) | United States | $9.220B | 13.40 |
| HealthEquity (HQY) | United States | $9.070B | 39.73 |
| Medpace Holdings (MEDP) | United States | $8.930B | 23.72 |
| Sonic Healthcare (SKHHY) | Australia | $8.455B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.368B | 14.44 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.386B | 25.83 |
| BrightSpring Health Services (BTSG) | United States | $4.138B | 37.97 |
| Sotera Health (SHC) | United States | $3.213B | 18.26 |
| Surgery Partners (SGRY) | United States | $2.813B | 36.58 |
| Alignment Healthcare (ALHC) | United States | $2.740B | 0.00 |
| Concentras Parent (CON) | United States | $2.711B | 15.67 |
| GeneDx Holdings (WGS) | United States | $2.599B | 100.11 |
| Organon (OGN) | United States | $2.563B | 2.72 |
| PACS (PACS) | United States | $1.980B | 0.00 |
| Ardent Health (ARDT) | United States | $1.957B | 8.34 |
| Progyny (PGNY) | United States | $1.878B | 41.34 |
| Premier (PINC) | United States | $1.779B | 13.51 |
| GoodRx Holdings (GDRX) | United States | $1.750B | 35.00 |
| Teladoc Health (TDOC) | United States | $1.475B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.205B | 9.17 |
| Establishment Labs Holdings (ESTA) | $1.184B | 0.00 | |
| CareDx (CDNA) | United States | $1.071B | 16.72 |
| Agilon Health (AGL) | United States | $0.956B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.919B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.840B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.799B | 7.48 |
| Nutex Health (NUTX) | United States | $0.683B | 10.34 |
| LifeMD (LFMD) | United States | $0.625B | 0.00 |
| Embecta (EMBC) | United States | $0.563B | 3.80 |
| InnovAge Holding (INNV) | United States | $0.529B | 0.00 |
| Enhabit (EHAB) | United States | $0.484B | 39.83 |
| SBC Medicals (SBC) | United States | $0.481B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.475B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.469B | 10.57 |
| Omada Health (OMDA) | $0.453B | 0.00 | |
| Performant Healthcare (PHLT) | United States | $0.313B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.259B | 0.00 |
| Beauty Health (SKIN) | United States | $0.246B | 0.00 |
| So-Young (SY) | China | $0.240B | 0.00 |
| Oncology Institute (TOI) | United States | $0.195B | 0.00 |
| DocGo (DCGO) | United States | $0.163B | 26.67 |
| Sera Prognostics (SERA) | United States | $0.154B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.120B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.092B | 0.00 |
| KindlyMD (NAKA) | United States | $0.086B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| ModivCare (MODV) | United States | $0.049B | 0.00 |
| Biodesix (BDSX) | United States | $0.037B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.034B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.032B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |